Potential Influence on Clinical Trials of Long-Term Survivors of Stage IV Non-small cell Lung Cancer by Davis, Jennifer S, Prophet, Erin, Peng, Ho-Lan, Lee, Hwa Young, Tidwell, Rebecca S S, Lee, J Jack, Thomas, Anish, Szabo, Eva, Chang, Shine

Get full text

Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities by Tahir, Salahaldin A., Gao, Jianjun, Miura, Yuji, Blando, Jorge, Tidwell, Rebecca S. S., Zhao, Hao, Subudhi, Sumit K., Tawbi, Hussein, Keung, Emily, Wargo, Jennifer, Allison, James P., Sharma, Padmanee

Get full text

Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer by Cowman, Sophie J, Fuja, Daniel G, Liu, Xian-De, Tidwell, Rebecca S Slack, Kandula, Neelima, Sirohi, Deepika, Agarwal, Archana M, Emerson, Lyska L, Tripp, Sheryl R, Mohlman, Jeffrey S, Stonhill, Miekan, Garcia, Guillermina, Conley, Christopher J, Olalde, Adam A, Sargis, Timothy, Ramirez-Torres, Adela, Karam, Jose A, Wood, Christopher G, Sircar, Kanishka, Tamboli, Pheroze, Boucher, Kenneth, Maughan, Benjamin, Spike, Benjamin T, Ho, Thai H, Agarwal, Neeraj, Jonasch, Eric, Koh, Mei Yee

Get full text

Increasing referral of at‐risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center by Arun, Banu K., Peterson, Susan K., Sweeney, Lilian E., Bluebond, Rachel D., Tidwell, Rebecca S. S., Makhnoon, Sukh, Kushwaha, Anne C.

Get full text

A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer by Aparicio, Ana M, Tidwell, Rebecca S S, Yadav, Shalini S, Chen, Jiun-Sheng, Zhang, Miao, Liu, Jingjing, Guo, Shuai, Pilié, Patrick G, Yu, Yao, Song, Xingzhi, Vundavilli, Haswanth, Jindal, Sonali, Zhu, Keyi, Viscuse, Paul V, Lebenthal, Justin M, Hahn, Andrew W, Soundararajan, Rama, Corn, Paul G, Zurita-Saavedra, Amado, Subudhi, Sumit K, Zhang, Jianhua, Wang, Wenyi, Huff, Chad, Troncoso, Patricia, Allison, James P, Sharma, Padmanee, Logothetis, Christopher J

Get full text

A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies by Lachowiez, Curtis A, Loghavi, Sanam, Zeng, Zhihong, Tanaka, Tomoyuki, Kim, Yi June, Uryu, Hidetaka, Turkalj, Sven, Jakobsen, Niels Asger, Luskin, Marlise R, Duose, Dzifa Y, Tidwell, Rebecca S S, Short, Nicholas J, Borthakur, Gautam, Kadia, Tapan M, Masarova, Lucia, Tippett, George D, Bose, Prithviraj, Jabbour, Elias J, Ravandi, Farhad, Daver, Naval G, Garcia-Manero, Guillermo, Kantarjian, Hagop, Garcia, Jacqueline S, Vyas, Paresh, Takahashi, Koichi, Konopleva, Marina, DiNardo, Courtney D

Get full text

A heavy metal baseline score predicts outcome in acute myeloid leukemia by Ohanian, Maro, Telouk, Philippe, Kornblau, Steven, Albarede, Francis, Ruvolo, Peter, Tidwell, Rebecca S. S., Plesa, Adriana, Kanagal‐Shamanna, Rashmi, Matera, Eva‐Laure, Cortes, Jorge, Carson, Arch, Dumontet, Charles

Get full text

Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune su... by Subudhi, Sumit K, Siddiqui, Bilal A, Aparicio, Ana M, Yadav, Shalini S, Basu, Sreyashi, Chen, Hong, Jindal, Sonali, Tidwell, Rebecca S S, Varma, Ashwin, Logothetis, Christopher J, Allison, James P, Corn, Paul G, Sharma, Padmanee

Get full text

Phase Ib/2 Study of Oral Decitabine/Cedazuridine (ASTX727) and Venetoclax in Combination with the Targeted Mutant IDH1 Inhibitor Ivosidenib or the Targeted Mutant IDH2 Inhibitor En... by Atluri, Himachandana, Mullin, Jillian, Takahashi, Koichi, Loghavi, Sanam, Maiti, Abhishek, Sasaki, Koji, Daver, Naval, Alvarado Valero, Yesid, Pemmaraju, Naveen, Borthakur, Gautam, Hammond, Danielle E., Chien, Kelly S., Ferrajoli, Alessandra, Short, Nicholas J., Abbas, Hussein A, Jabbour, Elias, Andreeff, Michael, Ravandi, Farhad, Tidwell, Rebecca S.S., Wang, Xuemei, Konopleva, Marina Y., Garcia-Manero, Guillermo, Kantarjian, Hagop M., DiNardo, Courtney D.

Get full text

Phase II Study of Carfilzomib in Patients With Refractory Renal Cell Carcinoma by Hasanov, Elshad, Tidwell, Rebecca S.S., Fernandez, Pablo, Park, Lauren, McMichael, Charla, Tannir, Nizar M., Jonasch, Eric

Get full text

Genotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) Components by Soundararajan, Rama, Viscuse, Paul, Pilie, Patrick, Liu, Jingjing, Logotheti, Souzana, Laberiano Fernández, Caddie, Lorenzini, Daniele, Hoang, Anh, Lu, Wei, Soto, Luisa Maren Solis, Wistuba, Ignacio I, Xu, Mingchu, Song, Xingzhi, Shepherd, Peter D A, Navone, Nora M, Tidwell, Rebecca S S, Lozano, Guillermina, Logothetis, Christopher, Zhang, Jianhua, Long, James P, Estecio, Marcos R, Tzelepi, Vasiliki, Aparicio, Ana M

Get full text

Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor) by Siddiqui, Bilal A, Chapin, Brian F, Jindal, Sonali, Duan, Fei, Basu, Sreyashi, Yadav, Shalini S, Gu, Ai-Di, Espejo, Alexsandra B, Kinder, Michelle, Pettaway, Curtis A, Ward, John F, Tidwell, Rebecca S S, Troncoso, Patricia, Corn, Paul G, Logothetis, Christopher J, Knoblauch, Roland, Hutnick, Natalie, Gottardis, Marco, Drake, Charles G, Sharma, Padmanee, Subudhi, Sumit K

Get full text